Duarte, CA, United States of America

John C Williams

This inventor holds 3 USPTO granted patents. Top assignee: City of Hope. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John C Williams. Retrieved from https://idiyas.com/inventor/john-c-williams-aqo1tryo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0


Company Filing History:


Years Active: 2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of John C. Williams

Introduction

John C. Williams is a notable inventor based in Duarte, California. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies. With a total of 3 patents to his name, Williams continues to push the boundaries of scientific research.

Latest Patents

Among his latest patents are "Meditopes and Meditope-Binding Antibodies and Uses Thereof" and "Anti-HVEM Antibodies." These inventions showcase his expertise in creating targeted therapies that have the potential to improve patient outcomes in various medical conditions.

Career Highlights

Williams is currently affiliated with City of Hope, a leading research and treatment center. His work at this institution has allowed him to collaborate with other experts in the field, further enhancing his contributions to medical science.

Collaborations

Some of his notable coworkers include Miso Park and Pamela J. Bjorkman. Their collaborative efforts have led to advancements in antibody research and development.

Conclusion

John C. Williams exemplifies the spirit of innovation in biotechnology through his patents and collaborative work. His contributions are paving the way for future advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…